The US Food and Drug Administration (FDA) has granted clearance to NxStage Medical’s System One hemodialysis device.

Formulated with new features and capabilities, the portable system comes with a touchscreen and integrated blood pressure monitor, allowing ease of use during at-home hemodialysis.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The FDA approval also covers home nocturnal hemodialysis.

NxStage Medical president Joseph Turk said: "Early customer and patient feedback on our next generation system has been very positive in the UK, validating many of the benefits we expected.

"We are very excited to bring these new features and capabilities to the US market, as they are designed to significantly improve our patients' therapy experience.

See Also:

“The touchscreen interface provides an excellent platform to continue bringing new features and functionality moving forward."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The touchscreen interface provides an excellent platform to continue bringing new features and functionality moving forward."

The small size of the device is expected to provide easy at-home use and convenient travel.

It further simplifies the procedure when combined with the NxStagePureFlow SL Dialysis Preparation system, which enables the use of ordinary tap water to create dialysis fluid as and when required.

The data from NxStage System One and patient information can be collected by the firm’s Nx2me Connected Health platform to allow flexible viewing, monitoring and reporting for improved patient management, retention and simple alternative site care.

With confirmed safety and performance via more than 14 million treatments with over 30,000 patients, the system can also be used for various therapies in standard care settings such as hospitals and dialysis centres.

Image: NxStage System One hemodialysis device. Photo: courtesy of PRNewsfoto/NxStage Medical Inc.